Sunday, April 20, 2025
HomePharma

Pharma

Pharma

Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva

Life Sciences Times - 0
Pharma

Alnylam Presents New 18-Month Results from Exploratory Cardiac Endpoints in HELIOS-A Phase 3 Study of Investigational Vutrisiran

Life Sciences Times - 0
Pharma

PharmaCyte Biotech Initiates Studies to Confirm Its Pancreatic Cancer Therapy Can Treat Malignant Ascites

Life Sciences Times - 0
Pharma

Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third...

Life Sciences Times - 0
Pharma

Rocket Pharmaceuticals Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and...

Life Sciences Times - 0
Pharma

Anji Pharma Completes Patient Enrollment in Phase 2 Study of Pradigastat in Functional Constipation

Life Sciences Times - 0
Pharma

Alzamend Neuro Announces Pre-IND Submission for AL001 as a Treatment of Bipolar Disorder, Major Depressive Disorder and Post-Traumatic Stress Disorder

Life Sciences Times - 0
Pharma

University of Nebraska Medical Center and ANANDA Scientific announce FDA approval of the IND for a Clinical Trial exploring Treatment for Post-Traumatic Stress Disorder

Life Sciences Times - 0
Pharma

New Milestone Clinical Study Shows Postbiotic Urolithin A (Mitopure™) Improves Muscle Strength and Exercise Performance in Middle Aged Adults

Life Sciences Times - 0
Pharma

Unlearn Receives Draft Qualification Opinion from European Medicines Agency for Using the PROCOVA™ Framework to Implement TwinRCTs™

Life Sciences Times - 0
Pharma

Nuvig Launches to Develop Novel Immune Therapeutics for Chronic Inflammatory and Autoimmune Diseases

Life Sciences Times - 0
Pharma

New Meta-Analysis in European Heart Journal’s Cardiovascular Pharmacotherapy Examines Cholesterol Ester Transfer Protein (CETP) Inhibitors’ Role in Reduction of Diabetes Risk

Life Sciences Times - 0
1...242526...62Page 25 of 62

Most Read

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: [email protected]

FOLLOW US

© Newspaper WordPress Theme by TagDiv